Last reviewed · How we verify
Placebo of HCP1105 — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of HCP1105 (Placebo of HCP1105) — Hanmi Pharmaceutical Company Limited. This is a placebo control and contains no active pharmaceutical ingredient.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of HCP1105 TARGET | Placebo of HCP1105 | Hanmi Pharmaceutical Company Limited | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of HCP1105 CI watch — RSS
- Placebo of HCP1105 CI watch — Atom
- Placebo of HCP1105 CI watch — JSON
- Placebo of HCP1105 alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of HCP1105 — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-hcp1105. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab